LiveNova Logo

TandemLife is now a part of LivaNova, Learn More Here.

COVID-19 UPDATES:The U.S. Food and Drug Administration (FDA) issued guidance on April 6, 2020 to temporarily expand the availability of devices used in extracorporeal membrane oxygenation (ECMO) therapy to address the novel coronavirus (COVID-19) public health emergency. As a result of the guidance, cardiopulmonary devices, including select devices from TandemLife | LivaNova, are now temporarily indicated for ECMO therapy greater than 6 hours. To read the full announcement, click here.



855 336 3051 REIMBURSEMENT

800 373 1607 US

412 507 6182 INTERNATIONAL

Clinical Research

TandemLife is dedicated to providing leading-edge technology and science to support patient care. New products are constantly being developed and old ones refined to better serve patients.

TandemLife is currently seeking motivated hospital centers that are passionate about advancing patient care to participate in the THEME Registry. Ideal participant centers will be characterized by at least one of the following:

  • Previous experience with the TandemLife platform
  • Willingness to report and share all of the aspects of device management from implant to explant
  • Desire to improve the body of knowledge for the treatment of multiple challenging disease states
  • Eagerness to share a variety of clinical outcomes with their peers in an unbiased forum
The THEME Registry utilizes an easy-to-use, validated database platform for the recording, management and reporting of all patient data: the MERGE eClinical OS. Registry participants will be trained by one of our registry experts, ensuring a quick and hassle-free start up.
The THEME Registry protocol is designed to capture data for patients who receive percutaneous placement of the device so that the characteristics of participating hospitals’ patient populations and clinical outcomes can be evaluated across a broad range of indications. Contributors will be asked to record pertinent patient and treatment-related information for each TandemLife case performed, both at the time of initial placement and at appropriate follow-up intervals.

Educational Grants

TandemLife supports the growing body of clinical science being conducted by individual physicians and treatment centers around the world through educational grants and sponsorships.
If you’re interested in an educational grant, please contact the LivaNova team by clicking the Grant Request link.


Product Development Advisory Team

We believe that innovation is driven by the partnership between companies and physicians.  If you have a product enhancement idea we should know about it, send it our way.  You could also join our physician advisory group or attend one of our regional TandemLife user meetings.  With your help we can design devices that will improve patient outcomes and move circulatory device innovation forward.